Influenza Activity and Composition of the 2022–23 Influenza Vaccine — United States, 2021

Influenza Activity and Composition of the 2022–23 Influenza Vaccine — United States, 2021–22 Season

Published:2022-07-22 Issue:29 Volume:71 Page:913-919
ISSN:0149-2195
Container-title:MMWR. Morbidity and Mortality Weekly Report
language:
Short-container-title:MMWR Morb. Mortal. Wkly. Rep.

Author:

Merced-Morales Angiezel¹,Daly Peter¹,Abd Elal Anwar Isa¹,Ajayi Noreen¹,Annan Ekow¹,Budd Alicia¹,Barnes John¹,Colon Arielle¹,Cummings Charisse N.¹,Iuliano A. Danielle¹,DaSilva Juliana¹,Dempster Nick¹,Garg Shikha¹,Gubareva Larisa¹,Hawkins Daneisha¹,Howa Amanda¹,Huang Stacy¹,Kirby Marie¹,Kniss Krista¹,Kondor Rebecca¹,Liddell Jimma¹,Moon Shunte¹,Nguyen Ha T.¹,O’Halloran Alissa¹,Smith Catherine¹,Stark Thomas¹,Tastad Katie¹,Ujamaa Dawud¹,Wentworth Dave E.¹,Fry Alicia M.¹,Dugan Vivien G.¹,Brammer Lynnette¹

Affiliation:

1. Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.

Publisher

Centers for Disease Control MMWR Office

Subject

Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology

Reference8 articles.

1. CDC. Emergency preparedness and response: highly pathogenic avian influenza A(H5N1) virus: recommendations for human health investigations and response. Atlanta, GA: US Department of Health and Human Services, CDC; 2022. https://emergency.cdc.gov/han/2022/han00464.asp

2. CDC. Influenza (flu): U.S. influenza surveillance: purpose and methods. Atlanta, GA: US Department of Health and Human Services, CDC; 2021. Accessed May 27, 2022. https://www.cdc.gov/flu/weekly/overview.htm

3. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2022–2023 northern hemisphere influenza season. Geneva, Switzerland: World Health Organization; 2022. https://cdn.who.int/media/docs/default-source/influenza/who-influenza-recommendations/vcm-northern-hemisphere-recommendation-2022-2023/202202_recommendation.pdf?sfvrsn=5c88e006_13

4. Food and Drug Administration. Summary minutes: 171st Vaccines and Related Biological Products Advisory Committee. Silver Spring, MD: US Department of Health and Human Serivices, Food and Drug Administration; 2022. https://www.fda.gov/media/157170/download

5. CDC. Influenza (flu): 2021–2022 U.S. flu season: preliminary in-season burden estimates. Atlanta, GA: US Department of Health and Human Services, CDC; 2022. Accessed May 27, 2022. https://www.cdc.gov/flu/about/burden/preliminary-in-season-estimates.htm

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multivalent next generation influenza virus vaccines protect against seasonal and pre-pandemic viruses;Scientific Reports;2024-01-16

2. Structural Studies of Inhibitors with Clinically Relevant Influenza Endonuclease Variants;Biochemistry;2024-01-08

3. Risk factors for hospitalization and pneumonia development of pediatric patients with seasonal influenza during February–April 2023;Frontiers in Public Health;2024-01-05

4. In‐field detection and characterization of B/Victoria lineage deletion variant viruses causing early influenza activity and an outbreak in Louisiana, 2019;Influenza and Other Respiratory Viruses;2024-01

5. Evaluation of FluSight influenza forecasting in the 2021-22 and 2022-23 seasons with a new target laboratory-confirmed influenza hospitalizations;2023-12-11